No more glasses? Scientists develop eye drops that could reverse poor eyesight; All you need to know

For millions of people who find themselves squinting at menus, struggling with small print, or constantly reaching for reading glasses, relief may soon come in the form of eye drops.

Argentinian scientists have revealed at an international ophthalmology conference in Denmark that they have developed drops which could act as an alternative to prescription spectacles for presbyopia, a natural, age-related condition where the eyes gradually lose the ability to focus on nearby objects. If proven safe, experts say the breakthrough could transform life for hundreds of millions worldwide.

What Exactly Is Presbyopia?

Presbyopia usually begins to set in after the age of 40. The condition occurs when the ring-shaped ciliary muscles, which allow the eye’s lenses to contract and relax, lose their flexibility with age. “After 40, there is a loss of elasticity in ciliary muscles. This condition is called presbyopia,” explained Dr Aditya Kelkar, director of the National Institute of Ophthalmology in Pune, to TOI.


Reading glasses have long been the simplest and most reliable fix. But according to WHO estimates, while 1.8 billion people globally have presbyopia, around 830 million remain uncorrected.

A Drop Instead of Glasses

As per TOI, researchers from the Center for Advanced Research of Presbyopia in Buenos Aires told the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) that they had created a solution showing quick improvements in vision. The eye drops, which combined pilocarpine (a drug already used in glaucoma treatment) in 1–3% concentrations with diclofenac suspended in an ophthalmic carrier, were tested on 766 people.

Lead researcher Giovanna Bennozzi reported that 80–90% of participants noticed improvements in near vision within an hour. On the standard Jaeger chart, many could read two to three extra lines compared to before using the drops.

Side effects such as mild irritation or dim vision were reported, but these resolved without intervention.

Experts Urge Caution

While the findings have raised hopes, ophthalmologists say the innovation must be treated with cautious optimism. Burkhard Dick, president-elect of ESCRS, who was not part of the research, noted that the results looked promising but stressed that larger trials would be crucial to confirm safety and accessibility.

Dr Kelkar also flagged concerns about the long-term impact of pilocarpine. “Long-term use may mean that the pupillary dilatation, which is important for cataract surgeries, may not be adequate. Will these drops make the patients predisposed to retinal detachment? These kinds of questions are still unanswered,” he told TOI.

He added that further research was required to refine the dosage. “Some people say 0.4% pilocarpine will do, some say 1% is enough. Initially, 2% was used in glaucoma treatment. The scientists are still fine-tuning these concentrations. A five-year follow-up will be crucial to understand the long-term effects.”

For now, reading glasses remain the most dependable solution. But if long-term trials confirm the safety of these drops, they could offer a glasses-free future to millions. Until then, experts say, cautious optimism is the best lens through which to view this breakthrough.